Restatement of Previously Issued Financial Statements (Tables)

10 Months Ended

Dec. 31, 2021

Accounting Changes and Error Corrections [Abstract]

Schedule of Financial Statements Adjustments

The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods, indicated:

	As previously reported			Adjustments			As restated
Balance Sheet - December 31, 2021
Accounts payable and accrued expenses	$	403,521		$	1,054,788		$	1,458,309
Total current liabilities		430,771			1,054,788			1,485,559
Total liabilities		19,396,171			1,054,788			20,450,959
Shareholders’ deficit
Accumulated deficit		(17,525,762	)		(1,054,788	)		(18,580,550	)
Total shareholders’ deficit	$	(17,525,340	)	$	(1,054,788	)	$	(18,580,128	)
	As Previously
	Reported			Adjustments			As restated
Statement of Operations – For the Period March 3, 2021 (inception) Through December 31, 2021
General and administrative expenses	$	6,984,048			1,054,788			8,038,836
Total expenses		7,039,048			1,054,788			8,039,836
Net loss		(2,523,613	)		(1,054,788	)		(3,578,400	)
Basic and diluted weighted average shares outstanding, redeemable Class A ordinary shares		9,059,406			—			9,059,406
Basic and diluted net loss per share of redeemable Class A ordinary shares	$	(0.19	)	$	(0.08	)	$	(0.27	)
Weighted average number shares of non-redeemable ordinary shares outstanding, basic and diluted		4,269,183			—			4,269,183
Basic and diluted net loss per share of non-redeemable ordinary shares	$	(0.19	)	$	(0.08	)	$	(0.27	)